Targeting microRNA (miRNA) as a unified therapeutic approach to the treatment of asthma and allergic inflammation

我们社区中约有30%的人患有过敏性炎症（哮喘/鼻炎/皮炎），导致生活质量低下。调节这些疾病的因素知之甚少，目前的治疗方法只针对症状，而不是疾病的原因。microRNA控制基因表达，并正在成为炎症的潜在调节因子。该项目将确定microRNA在调节过敏性疾病中的作用及其作为新治疗靶点的潜力。

Approximately 30% of our community suffers from allergic inflammation (asthma/rhinitis/dermatitis) that results in poor quality of life. The factors regulating these disorders are poorly understood and current treatments only target the symptoms and not the cause of disease. MicroRNA control gene expression and are emerging as potential regulators of inflammation. This project will identify the role of microRNA in the regulation of allergic diseases and their potential as new therapeutic targets.